QQQ $ 482.58 $ 2.69 (0.56 %)
DIA $ 391.33 $ 0.49 (0.13 %)
SPY $ 545.43 $ 1.69 (0.31 %)
TLT $ 90.42 $ -0.25 (-0.28 %)
GLD $ 215.17 $ -0.10 (-0.05 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tryp-submits-ind-application-to-fda-for-clinical-trial-of-psilocybin-assisted-psychotherapy-in-patients-with-ibs

Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S.

 tryp-therapeutics-secures-16m-via-oversubscribed-private-placement

Tryp Therapeutics Inc. (OTCQB: TRYPF) (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infu...

 fda-approves-psilocybin-for-binge-eating-study-by-tryp-therapeutics

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company in the medical psychedelics space, announced it has rece...

 psyched-detroit-decriminalizes-psychedelics-compass-to-study-psilocybin-for-ptsd-filaments-gets-first-ever-fda-approval

Detroit Decriminalizes Psychedelics Detroit is the latest to join the growing list of U.S. cities that have decriminalized psy...

 psyched-cybin-gets-9-price-target-fsd-pharma-acquires-lucid-new-trials-from-psilera-awakn-pharmadrug-and-braxia-california-bill-put-on-hold

Contents

 psyched-cybin-and-field-trip-head-to-wall-street-aoc-pushes-for-federal-psychedelics-research-off-label-ketamine-covered-by-insurance-in-canada

Cybin Inc.

 psyched-numinus-mindmed-cybin-reach-milestones-harvard-to-study-psychedelics-law-michael-pollan-dives-into-mescaline

Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...